Abstract Patients on renal replacement therapy are
ment of anaemia and the introduction of HCV Introduction screening of blood products and potential renal transplant donors, new cases of HCV are still being For almost two decades haemodialysis patients have documented, with patients on hospital haemodialysis been recognised as an at-risk group for developing appearing to be particularly at risk. The exact mode non-A, non-B ( NANB) hepatitis [1] . Despite significof transmission of HCV within dialysis units is ant advances in virology, including the identification unclear, although there is evidence to support nosocof hepatitis C as the principal cause of NANB hepatitis omial transmission between patients. Third generation
[2], our knowledge on the mode(s) of transmission of HCV antibody testing was performed on all dialysis this virus and its health implications in the haemodiapatients when a new case of HCV was identified lysis population remain incomplete. within our unit. Stored monthly serum samples were
In the dialysis population prevalence of HCV varies then examined retrospectively to determine when widely between countries [3-5 ] and also within the patients became HCV RNA and HCV antibody same country [6, 7] . These variations seem not simply positive. Viral typing was carried out to identify the to reflect local prevalence of HCV but rather suggest HCV strains responsible for transmission. Four new that some aspect (s) of the dialytic process may expose cases of HCV infection are described within a single patients to an increased risk of developing HCV. There dialysis shift. Viral typing identified two distinct is evidence of reduced rate of infection in patients strains of HCV as being responsible for these infecreceiving renal replacement therapy by continuous tions, both of which had previously been identified in ambulatory peritoneal dialysis (CAPD) [8] or home dialysis patients within the unit known to have HCV haemodialysis [9] compared to hospital haemodialysis. infection. This information, taken in conjunction with Originally this was thought to reflect the increased knowledge of the location of each patient for dialysis, requirement for blood transfusion in this population suggests two separate episodes of nosocomial trans-[6,10], however more recent studies have identified mission of HCV between haemodialysis patients. duration of haemodialysis to be a risk factor for HCV While evidence of nosocomial transmission of HCV infection independent of previous transfusions [11, 12] , is accumulating, with modern dialytic procedures suggesting transmission within the dialysis unit. The evidence of transmission through the dialysis machine identity of the exact 'vector' for transmission remains or equipment used for dialysis is lacking. This stresses unclear although two overlapping theories exist. The the importance of strict applications of universal first is that viable virus can survive regular sterilization precautions as the key to prevention of further and pass on to the next patient despite use of disposable transmission of HCV infection. This information is dialysis equipment. The second proposed mode of obviously applicable not only to dialysis units but all transmission is through environmental contamination, units that may potentially come in contact with HCV with breakdown in preventative measures facilitating patients.
person-to-person spread. This study details two episodes of transmission of HCV within temporally and geographically confined strains of HCV being identified suggesting two separate (RIBA-3, Chiron, Ortho). Selected sera from HCV episodes of nosocomial transmission between patients, antibody-positive patients taken before and after serothe first such episodes to be recorded in the UK, conversion were tested for HCV RNA by the Roche lending further credence to the theory that it is environ-Amplicor PCR (polymerase chain reaction) test mental contamination that is responsible for HCV (Roche Laboratories). All assays were carried out spread within dialysis units.
according to the manufacturers' guidelines.
Phylogenetic analysis

Subjects and methods
Typing of all positive HCV strains in the unit was Dialysis conditions carried out by restriction fragment length polymorphism (RFLP) analysis of viral sequences amplified in The unit concerned provides for 96 hospital haemodialysis the 5' non-coding region (NCR) by the method of patients on a thrice weekly basis with two dialysis shifts McOmish et al. [13] . Phylogenetic analysis of sequences daily. Dialysis machines are not moved between stations derived from patient samples was carried out by comand, wherever possible, patients occupy the same dialysis parison of a 222 base-pair fragment derived from the station. During the time of unknown HCV transmission NS5 region of the HCV genome. within the unit two specified machines were used to dialyse Virus was pelleted from samples by spinning 0.5 ml all known HCV-positive patients and no patients with hepatitis B were dialysed within the unit. Dialysis was carried out plasma at 100 000g for 1.5 h at 4°C. RNA was extracted using Fresenius 4008 machines and bicarbonate dialysate from the pellet by a method using lysis buffer con-(flow rate 500 ml/min) in all patients. Between dialysis ses-taining proteinase K followed by phenol/chloroform sions machine sterilization was carried out according to extraction. The RNA obtained was reverse-transcribed manufacturer recommendations using Citrosteril at 3% con-and amplified using nested primers from conserved in two separate reactions as described previously [14 ] . Further analysis of the different genotypes identified Virological monitoring was carried out by direct sequencing of positive samples in the NS5 region of HCV genome. Primers used were Prior to November 1994 the policy for virological 1204 and 1203 for the primary reaction followed by surveillance within our haemodialysis unit involved amplification of 1 ml of this product with either 123 sending serum specimens for routine virological testing and biotinylated 518 or 518 and biotinylated 123 as once per month for hepatitis B virus ( HBsAg) and described in Mellor et al. [15 ] . Sequence comparisons once every 6 months for antibody against hepatitis C were then carried out using a control group of epidemivirus ( HCV ) on all patients. Prior to starting haemoologically unrelated blood donors and patients infected dialysis HBsAg and anti-HCV status was known on with HCV type 1a (n = 79). These are presented as all patients. Anti-HCV testing was not available at rooted trees. that time as an emergency test, although a result was available during the next working day. No routine test is freely available to exclude acute infection in the Results potentially infectious patient.
The possibility of HCV infection was first raised when The four patients who seroconverted had been on two patients were noted to have deranged liver function haemodialysis for between 12 and 60 months. Two of tests (patients 3 and 4). Although HCV serology was the patients had previously been transfused (patient 3 negative when the liver function first became deranged, had received two units of blood electively in 1989 and repeat analysis showed seroconversion (anti-HCV+), patient 4 received two units at presentation in confirming, retrospectively, acute infection with HCV September 1991 ). No blood products had been given to be the cause of this. Sequential specimens (on all to any of the patients in the preceding year. All four patients) sent monthly for HBsAg testing were then patients had been treated exclusively by haemodialysis analysed retrospectively to establish when seroconverand none had previously been transplanted. Patients 1 sion had occurred and when HCV RNA was detectable. and 3 had both dialysed outside the unit on holiday Two further anti-HCV+ patients were thus identified but neither had done so in the 8 months preceding (patients 1 and 2 ). It is well recognized that renal seroconversion. Patient 3 was sexually active with a dialysis patients have reduced immune function and regular heterosexual partner while the other three antibody seroconversion dates may be misleading in patients denied being sexually active. The daughter of trying to pinpoint the exact time of transmission. The patient 2 is an intravenous drug misuser, otherwise the first detection of HCV RNA was considered to be the patients did not admit to lifestyle factors known to be most reliable indicator of recent infection. associated with HCV transmission. All sera were screened for antibody against HCV by
In January 1994 there were nine patients on renal Ortho third generation enzyme-linked immunosorbent replacement therapy (all on haemodialysis) within the assay ( ELISA). Supplemental testing of ELISA-reactive sera was by recombinant immunoblot assay unit who were known to be HCV antibody positive. 1a  4  2  2  0  1b  2  2  0  0  2  1  0  1  0  3  2  2 All antibody-positive patients were also known to have HCV RNA detectable by PCR. The HCV genotypes and modality of renal replacement are shown in Table 1 . The four patients who seroconverted occupied the same dialysis shift and were found to have the same HCV subtype (1a). Patients 1 and 3 had identical viral cDNA sequences which was also found in a patient known to be anti-HCV+ who dialysed on another shift (patient Y ). Patients 2 and 4 were also shown to have the same viral cDNA sequences which was found in a patient on the same dialysis shift known to be anti-HCV+ ( patient X ). The phylogenetic tree (Figure 1 ) shows the virus homology in the various patients. With the exception of patient X there were no other patients on the same shift as patients 1-4 who were known to be HCV positive or who have subsequently been diagnosed as such.
Viral cDNA sequencing suggests two independent viruses involved in transmission of HCV but does not identify the mechanism. To attempt to answer this question we studied the geographical location within the dialysis unit and timing of these patients becoming RNA and anti-HCV positive. Figure 2 shows the location of the dialysis stations for the four patients. In early 1994 patients 1 and 2 made a permanent swap of haemodialysis stations (for social reasons). It is geographical location, it would appear likely that not have been in the dialysis unit when patient 4 became infected. We would postulate that patient 1 sequential transmission occurred from X 2 4, which is strongly suggestive of nosocomial became infected while dialysing in the open ward adjacent to patient Y and then moved to the side room transmission.
The route of transmission in the remaining patients where further nosocomial spread occurred between patients 1 and 3. is less easily explained. As is common in most dialysis units, there is frequently a temporal overlap between morning and afternoon shifts which would, therefore,
Discussion
place patients 1 and Y at contiguous stations for a short period of time. During this time patient Y would have been ending dialysis while patient 1 was begin-There are several proposed mechanisms to explain the increased risk of HCV in patients treated by haemodianing. It is notable that patient Y received a cadaveric renal transplant in March 1994 and, therefore, would lysis. Undoubtedly, the use of non-screened blood
Finally, while the importance of HCV screening of mode of transmission is now largely historical, as has been confirmed by the fall in HCV prevalence within haemodialysis patients is recognized, this study illustrates another important aspect of monitoring of HCV units since this date [18] . Another possible vector is transmission via the dialysis apparatus. Transmission infection by highlighting the limitations of indirect indicators of infection, such as the delay of 4 months has been observed when non-disposable dialysis circuits are used [19 ] , although this is easily prevented by using before seroconversion in patients 2 and 4 and the lack of a significant elevation in transaminases in patient 2. entirely disposable circuits, as is the practice in the UK. While some authors have documented evidence PCR surveillance is not routinely available and is overly expensive to be considered as the recommended of HCV crossing the dialysis membrane [20] , a detailed study by Hubmann et al. [21 ] found no evidence of screening test for dialysis patients, although this technique could be useful in identifying HCV infection, if this, suggesting it to be an extremely rare occurrence. The clinical implications of this are likely to be further suspected, prior to seroconversion in patients with deranged liver function tests. In practical terms all reduced by the fact that the sterilization procedures employed in our unit are known to be virucidal to patients (and staff ) should be considered as being at risk of contracting HCV and universal precautions hepatitis B and, by implication, hepatitis C [22 ] .
Two independent episodes of HCV transmission against this should be religiously enforced. occurred in patients in close proximity within the unit.
The fact that these patients had never previously shared References the same dialysis machine suggests that transmission was nosocomial and may have been facilitated either 
